Recruiting Lung Cancer Studies in Marseille
Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs
The goal of this First-In-Human (FIH) Phase I/II trial is to establish the safety profile, determine the Recommended Phase II Dose (RP2D), explore the pharmacokinetic (PK) exposure and pharmacodynamic...
FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
The goal of this clinical trial is to investigate the safety, the activity of VERT-002 (PFL-002), and the optimal safe dose to be used, in participants with solid tumors including non-small cell lung ...
About Lung Cancer Clinical Trials in Marseille
Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.
There are currently 2 lung cancer clinical trials recruiting participants in Marseille, . These studies are seeking a combined 311 participants. Research is being sponsored by Pierre Fabre Medicament. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lung Cancer Clinical Trials in Marseille — FAQ
Are there lung cancer clinical trials in Marseille?
Yes, there are 2 lung cancer clinical trials currently recruiting in Marseille, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Marseille?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Marseille research site will contact you about next steps.
Are clinical trials in Marseille free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Marseille studies also compensate for your time and travel.
What lung cancer treatments are being tested?
The 2 active trials in Marseille are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.
Data updated March 2, 2026 from ClinicalTrials.gov